Advertisement

Prevention of Thromboembolism in Atrial Fibrillation: When Antiplatelet Agents and When Anticoagulants?

  • G. Di Pasquale
  • G. Pinelli
  • S. Urbinati
  • S. Biancoli
  • L. G. Pancaldi
  • A. Pozzati
  • S. Vinelli
  • B. Sassone
  • F. Ottani

Abstract

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice.

Keywords

Atrial Fibrillation International Normalize Ratio Stroke Prevention Atrial Fibrillation Patient Antithrombotic Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kannel WB, Abbott RD, Savage DD, McNamara PM (1982) Epidemiologic features of chronic atrial fibrillation. N Engl J Med 306: 1018–1022PubMedCrossRefGoogle Scholar
  2. 2.
    Laupacis A, Albers G, Dalen J, Dunn M, Feinberg W, Jacobson A (1995) Antithrombotic therapy in atrial fibrillation. Fourth ACCP Consensus Conference on Antithrombotic Therapy. Chest 108 (suppl): 352S - 359SPubMedCrossRefGoogle Scholar
  3. 3.
    Prytosky EN, Benson DW, Fuster V, Hart RG, Kay GN, Myerburg RJ, Naccarelli GV, Wyse DG (1996) Management of patients with atrial fibrillation. A statement for healthcare professionals from the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation 93: 1262–1277Google Scholar
  4. 4.
    Cerebral Embolism Task Force (1989) Cardiogenic brain embolism: the second report of the Cerebral Embolism Task Force. Arch Neurol 46: 727–743Google Scholar
  5. 5.
    Petersen P (1990) Thromboembolic complications in atrial fibrillation. Stroke 21: 4–13PubMedCrossRefGoogle Scholar
  6. 6.
    Cairns JA, Connolly SJ (1991) Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy. Circulation 84: 469–481Google Scholar
  7. 7.
    Hart RG (1992) Thromboembolism in nonrheumatic atrial fibrillation: what have we learned? In: Di Pasquale G, Pinelli G (eds) Heart-brain interactions. Springer, Berlin Heidelberg, pp 83–86CrossRefGoogle Scholar
  8. 8.
    The National Heart, Lung and Blood Institute Working Group on Atrial Fibrillation (1993) Atrial fibrillation: current undestandings and research imperatives. J Am Coll Cardiol 32: 1830–1834Google Scholar
  9. 9.
    Hart RG, Halperin JL (1994) Atrial fibrillation and stroke: revisiting the dilemmas. Stroke 25: 1337–1341PubMedCrossRefGoogle Scholar
  10. 10.
    Stein B, Fuster V, Halperin JL, Chesebro JH (1989) Antithrombotic therapy in cardiac disease. An emerging approach based on pathogenesis and risk. Circulation 80: 15011513Google Scholar
  11. 11.
    Chesebro JH, Fuster V, Halperin JL (1991) Atrial fibrillation: risk marker for stroke. N Engl J Med 323: 1556–1558CrossRefGoogle Scholar
  12. 12.
    Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B (1989) Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study. Lancet 1: 175–179Google Scholar
  13. 13.
    The Stroke Prevention in Atrial Fibrillation Investigators (1991) The Stroke Prevention in Atrial Fibrillation trial: final results. Circulation 84: 527–539CrossRefGoogle Scholar
  14. 14.
    The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators (1990) The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 325: 1505–1511Google Scholar
  15. 15.
    Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C, for the CAFA study coinvestigators (1991) Canadian Atrial Fibrillation Anticoagulation ( CAFA) study. J Am Coll Cardiol 18: 349–355Google Scholar
  16. 16.
    Ezekowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf H, Kurtzke JF, Nazarian SM, Radford MJ, Rickles FR, Shabetai R, Deykin D, for the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators (1992) Warfarin in the prevention of stroke associated with non-rheumatic atrial fibrillation. N Engl J Med 327: 1406–1412Google Scholar
  17. 17.
    The Stroke Prevention in Atrial Fibrillation Investigators (1992) Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Intern Med 116: 1–5CrossRefGoogle Scholar
  18. 18.
    Atrial Fibrillation Investigators (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 154: 1449–1457CrossRefGoogle Scholar
  19. 19.
    Di Pasquale G, Urbinati S, Ribani MA, Passarelli P, Pinelli G (1994) Clinical markers of embolic risk in patients with atrial fibrillation. G Ital Cardiol 24: 315–324PubMedGoogle Scholar
  20. 20.
    Kopecky Sl, Gersh BJ, Mc Goon MD, Whisnant JP, Holmes DR Jr, Ilstrup DM, Frye RL (1987) The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med 327: 1406–1412Google Scholar
  21. 21.
    The Stroke Prevention in Atrial Fibrillation Investigators (1992) Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. Ann Intern Med 116: 6–12CrossRefGoogle Scholar
  22. 22.
    Di Pasquale G, Urbinati S, Pinelli G (1995) “New echocardiographic markers of embolic risk in atrial fibrillation”. Cerebrovasc Dis 5: 315–322CrossRefGoogle Scholar
  23. 23.
    Stroke Prevention in Atrial Fibrillation Investigators (1994) Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 346: 687–691Google Scholar
  24. 24.
    European Atrial Fibrillation Trial (EAFT) Study Group (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 342: 1255–1262Google Scholar
  25. 25.
    Cataldo G, SIFA Study Group (1995) Secondary prevention of stroke in non-valvular atrial fibrillation: results of the SIFA (Studio Italiano Fibrillazione Atriale). J Am Coll Cardiol (Suppl) 144A (abstr)Google Scholar
  26. 26.
    Patrono C (1994) Aspirin as an antiplatelet drug. N Engl J Med 330: 1287–1294PubMedCrossRefGoogle Scholar
  27. 27.
    Miller VT, Rothrock JF, Pearce LA, Feinberg WM, Hart RG, Anderson DC (1993) Ischemic stroke in patients with atrial fibrillation: clinical characteristics and the effect of aspirin. Neurology 43: 32–36PubMedCrossRefGoogle Scholar
  28. 28.
    Stroke Prevention in Atrial Fibrillation Investigators (1996) Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 348: 633–638CrossRefGoogle Scholar
  29. 29.
    Di Pasquale G, Ribani MA, Urbinati S, Passarelli P, Pinelli G (1995) Come si deve trattare oggi la fibrillazione atriale. In: Prati PL (ed) Conoscere e curare it cuore ’85. CIBA Edizioni, Milano, pp 285–299Google Scholar
  30. 30.
    Palareti G, Leali N, Coccheri S et al on behalf of the Italian Study on Complications of Oral Anticoagulant Therapy (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study ( ISCOAT ). Lancet 348: 423–428Google Scholar
  31. 31.
    Hylek EM, Skates SJ, Sheehan MA, Singer DE (1996) An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 335: 540–546PubMedCrossRefGoogle Scholar
  32. 32.
    Gage BF, Cardinalli AB, Albers GW, Owens DK (1995) Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation JAMA 274: 1839–1845Google Scholar

Copyright information

© Springer-Verlag Italia 1998

Authors and Affiliations

  • G. Di Pasquale
    • 1
  • G. Pinelli
    • 2
  • S. Urbinati
    • 2
  • S. Biancoli
    • 1
  • L. G. Pancaldi
    • 1
  • A. Pozzati
    • 1
  • S. Vinelli
    • 1
  • B. Sassone
    • 1
  • F. Ottani
    • 1
  1. 1.Divisione di CardiologiaOspedale di BentivoglioBolognaItaly
  2. 2.Ospedale BellariaBolognaItaly

Personalised recommendations